Skip to main content
EAXR
OTC Technology

Ealixir Registers 22.6M-Share Resale; Going Concern and Reverse Split Disclosed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Technology
Sentiment info
Negative
Importance info
8
Price
$0.55
Mkt Cap
$33.067M
52W Low
$0.212
52W High
$4.99
52W Position info
159% above low
Off High info
89% below high
Rel. Volume info
3.8× avg
Market data snapshot near publication time

EAXR has more than doubled off its 52-week low of $0.212 on elevated volume (3.8× avg).

Summary

Ealixir registered 22.6M shares for insider resale — roughly 37.6% of shares outstanding — while disclosing a going-concern opinion, a $605,826 stockholders' deficit, and a planned 1-for-2 to 1-for-4 reverse split.


Key Events · Financing and Capital Events · EAXR

  • 22.6M Shares Registered for Resale

    Amendment No. 2 registers 22,602,658 shares held by ~48 selling stockholders, equal to about 37.6% of the 60,121,536 shares outstanding. Ealixir receives no proceeds; the selling holders pay their own commissions.

  • Going Concern and Thin Liquidity

    Auditor RBSM LLP included a going-concern paragraph in the 2025 audit report, and management cites substantial doubt about the next 12 months. Cash stood at $89,868 at June 30, 2026, against a $605,826 stockholders' deficit.

  • Reverse Split Planned Post-Offering

    A reverse split of 1-for-2 to 1-for-4 is planned after the offering closes, with the exact ratio at Board discretion and authorized common stock reduced by the same ratio.

  • CEO Controls 93.7% of Votes

    Eleonora Ramondetti holds 1,000,000 Series Z Preferred shares carrying 900 votes each, giving her about 93.7% of total voting power and controlled-company status.


Analysis · EAXR · Technology

The overhang is the story: Ealixir filed Amendment No. 2 to its S-1 to register 22,602,658 shares for resale by roughly 48 selling stockholders — about 37.6% of the 60,121,536 shares outstanding (22,602,658 / 60,121,536). None of the proceeds go to the company, and those holders can sell into the OTC Pink market at any time. Against that, the filing carries a going-concern opinion from auditor RBSM LLP and management's own statement of substantial doubt about the next 12 months, with only $89,868 of cash at June 30, 2026 and operations funded by related-party loans from Danila Pisati. A reverse split of 1-for-2 to 1-for-4 is planned after the offering closes, with the exact ratio left to the Board. Because CEO Eleonora Ramondetti controls about 93.7% of voting power through Series Z Preferred, minority holders have little say over any of it.

How filings like this one have moved

In the 30 days to Oct 21, 2026, 37.2% of the 999 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.80%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EAXR was trading at $0.55 on OTC in the Technology sector, with a market capitalization of approximately $33.1M. The 52-week trading range was $0.21 to $4.99. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EAXR - Latest Insights

EAXR
May 27, 2026, 4:58 PM EDT
Filing Type: S-1/A
Importance Score:
8
Price at Filing: $2.00
Real-time Price: $0.550 info
Change: -$1.45 (-73%) info
Market Cap: $33.067M info